MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2024-25)
- Udyam number
- UDYAM-MP-24-0012006
_PRIVATE_LIMITED.webp)
Daymark Pharmaceuticals (India) Private Limited - healthcare in Jabalpur, Madhya Pradesh, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹1.7 Cr
▲ 17% YoY
Net profit · FY 2025
₹21,875
Net margin 0.1%
EBITDA · FY 2025
₹16.95 Lakh
EBITDA margin 10%
Authorised capital
₹21 Lakh
Registered with MCA
Paid-up capital
₹19.02 Lakh
Issued & subscribed
Open charges
₹1 Cr
Secured borrowings
Company age
28 yrs
Est. 1998
Directors on board
2
As per MCA filings
About Daymark Pharmaceuticals (India) Private Limited
Data last updated:
Daymark Pharmaceuticals (India) Private Limited is a private limited company based in Jabalpur, Madhya Pradesh, India. It operates in the ayurvedic products and services segment of the healthcare sector. It was incorporated on 06 April 1998 and has been in existence for over 28 years.
The company is registered with the Registrar of Companies (ROC), Gwalior, under CIN U24232MP1998PTC012746. Its GSTIN is 23AABCD6034B1ZE (Madhya Pradesh).
The company has an authorised share capital of ₹21 Lakh and a paid-up capital of ₹19.02 Lakh. It is led by directors Bhagwandas Batheja (Managing Director) and Anjali Batheja (Whole-Time Director).
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Jabalpur, Madhya Pradesh.
As per the financials filed for FY 2025, the company reported a revenue of ₹1.7 Cr, a growth of 17% compared to the previous year. For the same year it recorded a net profit of ₹21,875 (net margin 0.1%) and EBITDA of ₹16.95 Lakh (EBITDA margin 10%). Revenue has grown at a compounded annual rate (CAGR) of 14% over three years and 14% over five years.
As per MCA filings, the company has open charges of ₹1 Cr on record.
Daymark Pharmaceuticals (India) Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-MP-24-0012006). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website daymarkpharma.com.
Company details
CIN U24232MP1998PTC012746
Registration Number 012746
Incorporation Date 06 April 1998
ROC Gwalior
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
MSME Classification Micro
Udyam Registration UDYAM-MP-24-0012006
Recognitions & Rankings of Daymark Pharmaceuticals (India)
Contact details
Daymark Pharmaceuticals (India) Private Limited's registered office is in Jabalpur, Madhya Pradesh. Its website is daymarkpharma.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered AddressPlot No. 10, Village Sihoda, Jabalpur, Madhya Pradesh, India – 483053
- IndustryHealthcare, Ayurvedic Products & Services
To see the full contact details of Daymark Pharmaceuticals (India) Private Limited, buy the company report.
Comprehensive company report
Daymark Pharmaceuticals (India) Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Daymark Pharmaceuticals (India) is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Daymark Pharmaceuticals (India) Private Limited, buy the company report.
Financials of Daymark Pharmaceuticals (India) Private Limited
FY 2025 filings availableDaymark Pharmaceuticals (India) Private Limited reported revenue of ₹1.7 Cr (up 17% YoY) for FY 2025.
Revenue · FY 2025
₹1.7 Cr ▲ 17%
Net profit · FY 2025
₹21,875 margin 0.1%
EBITDA · FY 2025
₹16.95 Lakh margin 10%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 17%
3 years · compounded
▲ 14%
5 years · compounded
▲ 14%
EBITDA CAGR growth
1 year
▼ 3%
3 years · compounded
▲ 395%
5 years · compounded
▲ 63%
Revenue has grown at a compounded annual rate (CAGR) of 14% over five years, including 17% growth in the latest year. EBITDA fell 3% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹16.95 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹21,875 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 10% | ||||
| Net Profit Margin | 0.1% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Daymark Pharmaceuticals (India) Private Limited, buy the company report.
Board of directors of Daymark Pharmaceuticals (India) Private Limited
Daymark Pharmaceuticals (India) has 2 directors on record. No former directors are listed.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Bhagwandas Batheja | Managing Director | 06 Apr 1998 | 28 Years 6 Months | Current |
| Anjali Batheja | Whole-Time Director | 06 Apr 1998 | 28 Years 6 Months | Current |
Auditor
Daymark Pharmaceuticals (India) Private Limited is audited by MSVP & COMPANY for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| MSVP & COMPANY | FY 2023 | 430933 |
Shareholding
The shareholding of Daymark Pharmaceuticals (India) Private Limited is on record for 5 financial years, the latest being FY 2022, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Daymark Pharmaceuticals (India) Private Limited, buy the company report.
Charges & borrowings
Open charges
₹1 Cr
Satisfied charges
None
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 18 Feb 2004 | 90209478 | Others | ₹1 Cr | Open |
To see the full charge records of Daymark Pharmaceuticals (India) Private Limited, buy the company report.
Total charge records: 1 View all charges
Legal cases
No court or tribunal cases involving Daymark Pharmaceuticals (India) Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Daymark Pharmaceuticals (India) Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Daymark Pharmaceuticals (India) has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 23AABCD6034B1ZE | Madhya Pradesh | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Daymark Pharmaceuticals (India) Private Limited, buy the company report.
Recent activity
Daymark Pharmaceuticals (India) Private Limited has 2 board changes on record since 1998: 2 appointments. The latest: Anjali Batheja was appointed as Whole-Time Director on 06 Apr 1998.
AGM
Daymark Pharmaceuticals (India) Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Daymark Pharmaceuticals (India) Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Gwalior.
Charges
A charge with Others of Rs. 100.00 Lakh registered on 18 Feb 2004 with Charge ID 90209478 was modified on 15 Feb 2022.
Charges
A charge with Others amounted to Rs. 100.00 Lakh with Charge ID 90209478 was registered on 18 Feb 2004.
Appointed
Anjali Batheja was appointed as Whole-Time Director.
Appointed
Bhagwandas Batheja was appointed as Managing Director.
Incorporation
06 Apr 1998
Daymark Pharmaceuticals (India) Private Limited was registered on 06 Apr 1998 with Roc Gwalior & aged 28 years 6 months as per MCA records.
Frequently asked questions
Daymark Pharmaceuticals (India) is an active private limited company based in Jabalpur, Madhya Pradesh, India. The company works in ayurvedic products and services, within the healthcare industry. It was incorporated on 06 April 1998 (28+ years old) and is registered under CIN U24232MP1998PTC012746.
Daymark Pharmaceuticals (India) has 2 current directors:
- Bhagwandas Batheja - Managing Director
- Anjali Batheja - Whole-Time Director
The latest financial statements of Daymark Pharmaceuticals (India) on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Daymark Pharmaceuticals (India) is 23AABCD6034B1ZE, registered in Madhya Pradesh.
The CIN (Corporate Identification Number) of Daymark Pharmaceuticals (India) is U24232MP1998PTC012746. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Daymark Pharmaceuticals (India) was incorporated on 06 April 1998, making it 28+ years old. It is registered with the Registrar of Companies, Gwalior.
Anjali Batheja was appointed as Whole-Time Director on 06 Apr 1998. Bhagwandas Batheja was appointed as Managing Director on 06 Apr 1998.
Yes, Daymark Pharmaceuticals (India) is registered as a micro enterprise under Udyam registration (number: UDYAM-MP-24-0012006).
Daymark Pharmaceuticals (India) can be reached through the website daymarkpharma.com. Its registered office is in Jabalpur, Madhya Pradesh, India.
The registered office of Daymark Pharmaceuticals (India) is at Plot No. 10, Village Sihoda, Jabalpur, Madhya Pradesh, India – 483053.